Position in BCYC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,662,770
+$650,717 QoQ
Shares Held
392,163
+79.8% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 103 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Derivatives in BCYC
reported options exposure · as of Jun 30, 2026CallValue
$151,792
CallShares
35,800
PutValue
$113,632
PutShares
26,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. BCYC ranks #67 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in BCYC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,792 | 35,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $113,632 | 26,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,662,770 | 392,163 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,012,053 | 218,115 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $393,936 | 84,900 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $447,384 | 63,190 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $104,784 | 14,800 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $793,032 | 102,459 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $157,117 | 22,607 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $335,874 | 23,991 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $456,671 | 20,180 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $300,968 | 14,870 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $502,903 | 20,197 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $1,499,735 | 82,950 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $991,923 | 49,374 | Shares | Defined | 2023-11-15 | |
| 2023-03-31 | $208,445 | 9,800 | Shares | Defined | 2023-05-16 | |
| 2022-03-31 | $350,645 | 7,991 | Shares | Defined | 2022-05-17 | |
| 2022-03-31 | $250,116 | 5,700 | Call | Defined | 2022-05-17 | |
| 2021-12-31 | $814,805 | 13,386 | Shares | Defined | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||